Almirall

Almirall, founded in 1943, is a distinguished global biopharmaceutical company with a primary focus on medical dermatology. Operating within the Pharmaceuticals and Healthcare sectors, the company has established a significant presence through its dedicated research, development, manufacturing, and commercialization of innovative prescription treatments. Its long-standing history underscores a commitment to advancing dermatological care.

The company specializes in addressing critical skin diseases, including psoriasis, atopic dermatitis, and actinic keratosis. Almirall's operational scope encompasses a robust pipeline of therapeutic solutions, driven by a strong emphasis on scientific innovation and R&D efforts. With a workforce ranging from 1,000-5,000 employees and operations across 8 locations, Almirall leverages its extensive experience to bring valuable medical advancements to patients worldwide.

Almirall's strategic approach involves developing novel therapies and fostering collaborations to expand its portfolio of dermatological products. The company's revenue stands at $1.3B, reflecting its substantial market impact. To understand the individuals driving these advancements and the company's organizational structure, you can Meet Almirall's team. This focus on both scientific progress and human capital positions Almirall as a key player in the global biopharmaceutical landscape.